Bliss GVS Pharma Ltd. benchmarking: Perfomance to industry peers

Financial

	Bliss GVS Pharma	Beta Drugs	Novartis
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	2.7 %	n/a	n/a
Financials
5 yr Average ROE	6.83 %	22.74 %	8.0 %
5yr average Equity Multiplier	1.3	1.82	2.72
5yr Average Asset Turnover Ratio	0.62	1.03	0.18
5yr Avg Net Profit Margin	8.7 %	12.23 %	17.12 %
Price to Book	1.41	8.35	2.52
P/E	14.52	38.81	18.3
5yr Avg Cash Conversion Cycle	186.56 Days	7.75 Days	-23.33 Days
Inventory Days	54.35 Days	46.07 Days	44.27 Days
Days Receivable	189.93 Days	91.57 Days	38.18 Days
Days Payable	75.78 Days	119.03 Days	124.28 Days
5yr Average Interest Coverage Ratio	14.68	14.42	65.43
5yr Avg ROCE	13.27 %	27.84 %	5.91 %
5yr Avg Operating Profit Margin	17.03 %	21.76 %	15.15 %
5 yr average Debt to Equity	0.11	0.29	0.0
5yr CAGR Net Profit	4.24 %	29.34 %	37.01 %
5yr Average Return on Assets	5.31 %	12.69 %	3.13 %
Shareholdings
Promoter Holding	35.39 %	66.73 %	70.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.84 %	0.02 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Bliss GVS Pharma	Beta Drugs	Novartis
Product Wise Break-Up	Product Wise Break-Up Anti Malarials 43.0 Anti-fungal 16.0 Anti Inflammatory 7.0 Antibiotics 5.0 Anti-bacterial 0 Manufacturing of Oncology medicines 0 0 Others 29.0	Product Wise Break-Up 0 Antibiotics 0 Anti Malarials 0 Oncology 100.0 Anti Inflammatory 0 Anti-bacterial 0 Anti-fungal 0	Product Wise Break-Up Wholesale of pharmaceuticals and medical goods 100.0 Antibiotics 0 Anti Malarials 0 Manufacturing of Oncology medicines 0 Anti Inflammatory 0 Anti-bacterial 0 Anti-fungal 0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 93.39 India 6.61 Domestic 0	Location Wise Break-Up India 71.03 India 0 Rest of the World 0 Others 28.97	Location Wise Break-Up Domestic 0 India 100.0 Rest of the World 0